FNDC5 and osteoporosis: Bone diseases, such as osteoporosis and rheumatoid arthritis, can significantly lower an individual’s quality of life and, thus, more research should be performed to examine if exogenous irisin administration can promote bone health in aging populations and individuals with bone-related diseases.